288 related articles for article (PubMed ID: 16434314)
1. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
[TBL] [Abstract][Full Text] [Related]
2. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
3. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
4. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
[TBL] [Abstract][Full Text] [Related]
5. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
Wu W; Xue YQ; Wu YF; Pan JL; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
[TBL] [Abstract][Full Text] [Related]
6. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
7. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
Reid AG; Tarpey PS; Nacheva EP
Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
9. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
[TBL] [Abstract][Full Text] [Related]
10. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
[TBL] [Abstract][Full Text] [Related]
11. Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients.
Storlazzi CT; Specchia G; Anelli L; Albano F; Pastore D; Zagaria A; Rocchi M; Liso V
Genes Chromosomes Cancer; 2002 Nov; 35(3):271-6. PubMed ID: 12353269
[TBL] [Abstract][Full Text] [Related]
12. [A molecular cytogenetic study on chromosome anomalies of chronic myeloid leukemia].
Zhu B; Shen X; Li C; Lai X; Li Y; Shi K; Feng H; Wang R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):116-8. PubMed ID: 10751535
[TBL] [Abstract][Full Text] [Related]
13. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
Batista DA; Hawkins A; Murphy KM; Griffin CA
Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
[TBL] [Abstract][Full Text] [Related]
16. e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia.
Roti G; La Starza R; Gorello P; Gottardi E; Crescenzi B; Martelli MF; Mecucci C
Haematologica; 2005 Aug; 90(8):1139-41. PubMed ID: 16079118
[TBL] [Abstract][Full Text] [Related]
17. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
[TBL] [Abstract][Full Text] [Related]
18. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia.
Yoong Y; VanDeWalker TJ; Carlson RO; Dewald GW; Tefferi A
Eur J Haematol; 2005 Feb; 74(2):124-7. PubMed ID: 15654903
[TBL] [Abstract][Full Text] [Related]
20. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]